These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

482 related items for PubMed ID: 12860778

  • 1. Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS.
    Lyketsos CG, DelCampo L, Steinberg M, Miles Q, Steele CD, Munro C, Baker AS, Sheppard JM, Frangakis C, Brandt J, Rabins PV.
    Arch Gen Psychiatry; 2003 Jul; 60(7):737-46. PubMed ID: 12860778
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparison of three rating scales as outcome measures for treatment trials of depression in Alzheimer disease: findings from DIADS.
    Mayer LS, Bay RC, Politis A, Steinberg M, Steele C, Baker AS, Rabins PV, Lyketsos CG.
    Int J Geriatr Psychiatry; 2006 Oct; 21(10):930-6. PubMed ID: 16955427
    [Abstract] [Full Text] [Related]

  • 4. A double-blind, placebo-controlled study comparing the effects of sertraline versus amitriptyline in the treatment of major depression.
    Lydiard RB, Stahl SM, Hertzman M, Harrison WM.
    J Clin Psychiatry; 1997 Nov; 58(11):484-91. PubMed ID: 9413414
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A randomized, placebo-controlled study of the efficacy and safety of sertraline in the treatment of the behavioral manifestations of Alzheimer's disease in outpatients treated with donepezil.
    Finkel SI, Mintzer JE, Dysken M, Krishnan KR, Burt T, McRae T.
    Int J Geriatr Psychiatry; 2004 Jan; 19(1):9-18. PubMed ID: 14716694
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Randomized, double-blind comparison of venlafaxine and sertraline in outpatients with major depressive disorder. Venlafaxine 631 Study Group.
    Mehtonen OP, Søgaard J, Roponen P, Behnke K.
    J Clin Psychiatry; 2000 Feb; 61(2):95-100. PubMed ID: 10732656
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Double-blind comparison of sertraline and placebo in stroke patients with minor depression and less severe major depression.
    Murray V, von Arbin M, Bartfai A, Berggren AL, Landtblom AM, Lundmark J, Näsman P, Olsson JE, Samuelsson M, Terént A, Varelius R, Asberg M, Mårtensson B.
    J Clin Psychiatry; 2005 Jun; 66(6):708-16. PubMed ID: 15960563
    [Abstract] [Full Text] [Related]

  • 14. Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes.
    Weintraub D, Rosenberg PB, Drye LT, Martin BK, Frangakis C, Mintzer JE, Porsteinsson AP, Schneider LS, Rabins PV, Munro CA, Meinert CL, Lyketsos CG, DIADS-2 Research Group.
    Am J Geriatr Psychiatry; 2010 Apr; 18(4):332-40. PubMed ID: 20220589
    [Abstract] [Full Text] [Related]

  • 15. Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo-controlled trial.
    Lustman PJ, Clouse RE, Nix BD, Freedland KE, Rubin EH, McGill JB, Williams MM, Gelenberg AJ, Ciechanowski PS, Hirsch IB.
    Arch Gen Psychiatry; 2006 May; 63(5):521-9. PubMed ID: 16651509
    [Abstract] [Full Text] [Related]

  • 16. Do treatment effects vary among differing baseline depression criteria in depression in Alzheimer's disease study ± 2 (DIADS-2)?
    Drye LT, Martin BK, Frangakis CE, Meinert CL, Mintzer JE, Munro CA, Porsteinsson AP, Rabins PV, Rosenberg PB, Schneider LS, Weintraub D, Lyketsos CG, DIADS-2 Research Group.
    Int J Geriatr Psychiatry; 2011 Jun; 26(6):573-83. PubMed ID: 20672243
    [Abstract] [Full Text] [Related]

  • 17. Citalopram versus sertraline in late-life nonmajor clinically significant depression: a 1-year follow-up clinical trial.
    Rocca P, Calvarese P, Faggiano F, Marchiaro L, Mathis F, Rivoira E, Taricco B, Bogetto F.
    J Clin Psychiatry; 2005 Mar; 66(3):360-9. PubMed ID: 15766303
    [Abstract] [Full Text] [Related]

  • 18. An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression.
    Schneider LS, Nelson JC, Clary CM, Newhouse P, Krishnan KR, Shiovitz T, Weihs K, Sertraline Elderly Depression Study Group.
    Am J Psychiatry; 2003 Jul; 160(7):1277-85. PubMed ID: 12832242
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Sertraline for the treatment of depression in Alzheimer disease.
    Rosenberg PB, Drye LT, Martin BK, Frangakis C, Mintzer JE, Weintraub D, Porsteinsson AP, Schneider LS, Rabins PV, Munro CA, Meinert CL, Lyketsos CG, DIADS-2 Research Group.
    Am J Geriatr Psychiatry; 2010 Feb; 18(2):136-45. PubMed ID: 20087081
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.